Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,230.12
(
0.29%
)
US TECH 100
26,942.00
(
0.87%
)
Dow Jones
49,499.27
(
-0.31%
)
Brent Oil
107.80
(
0.00%
)
Bitcoin
78,404.07
(
-0.35%
)
News Focus
News Focus
Post# of 20617
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Biotech Pharmer

Send PM Follow Ignore
Followers 0
Posts 1521
Boards Moderated 0
Alias Born 09/16/2005

Biotech Pharmer

Re: klimanjaro post# 11031

Wednesday, 08/09/2017 2:16:41 PM

Wednesday, August 09, 2017 2:16:41 PM

Post# of 20617
they caved in and are paying a premium to Hikma Pharm to manufacture it under their existing ANDA. Should have done that long ago rather than waiting for allergy season to be over and placing a big order that's going to throw another monkey wrench into Q3 SG&A. I maintain my opinion that this CEO either doesn't think things through or just doesn't give a damn about the financials/share price.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today